Horizon Therapeutics plc announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...
Jabil Inc. introduced PLA 3110P, a novel powder based on a renewably sourced biomaterial that offers a bio-based alternative to petrochemical-based powders, such as...
Alnylam Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. announced positive interim results from the ongoing single ascending dose part of the Phase 1 study of...
